Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shin-Yi Lin, Yi-Wen Chen, Hao-Cheng Kang, Yee-Jen Wu, Pin-Zi Chen, Chia-Wei Wu, Chii-Shan Lin, Fe-Lin Lin Wu, Li-Jiuan Shen, Yen-Ming Huang & Chih-Fen Huang. (2021) Effects of a pharmacist-managed anticoagulation outpatient clinic in Taiwan: evaluation of patient knowledge, satisfaction, and clinical outcomes. Postgraduate Medicine 133:8, pages 964-973.
Read now
Read now
Román Freixa-Pamias, Pedro Blanch Gràcia, Maria Lluïsa Rodríguez Latre, Luca Basile, Pilar Sanchez Chamero, Manuel Gomez-Choco, Pedro Armario, Antoni Martínez-Rubio & Josep Lupón. (2021) Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke. Current Medical Research and Opinion 37:3, pages 357-365.
Read now
Read now
Cesar Caro Martinez, Juan José Cerezo Manchado, Pedro José Flores Blanco, Ginés Elvira Ruíz, Helena Albendín Iglesias, Alejandro Lova Navarro, Francisco Arregui Montoya, Arcadio García Alberola, Domingo Andrés Pascual Figal, Jose Luis Bailén Lorenzo, Begoña Navarro-Almenzar, Faustino García-Candel & Sergio Manzano Fernández. (2019) Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry. Current Medical Research and Opinion 35:8, pages 1463-1471.
Read now
Read now
Niklas Ekerstad, Thomas Karlsson, Sara Söderqvist & Björn W Karlson. (2018) Hospitalized frail elderly patients – atrial fibrillation, anticoagulation and 12 months’ outcomes. Clinical Interventions in Aging 13, pages 749-756.
Read now
Read now
José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Vanessa Roldán, Francisco Marín & Gregory Y.H. Lip. (2017) Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Expert Opinion on Drug Safety 16:9, pages 1051-1062.
Read now
Read now
Articles from other publishers (21)
Banafsheh Shakibajahromi, Scott E. Kasner, Catherine Schmitt & Christopher G. Favilla. (2023) Anticoagulation under-utilization in atrial fibrillation patients is responsible for a large proportion of strokes requiring endovascular therapy. Journal of Stroke and Cerebrovascular Diseases 32:3, pages 106980.
Crossref
Crossref
Jahaan Ali, Reza Abbasi-Dezfouly, Sheny Khera, Paul Kivi & Peter George Jaminal Tian. (2023) Family Physician Prescribing Practices and Perspectives on Shared Decision-Making Regarding the Use of Oral Anticoagulants for Stroke Prevention in Patients 75 Years or Older With Atrial Fibrillation. Journal of Primary Care & Community Health 14, pages 215013192311640.
Crossref
Crossref
Anne Grete Semb, Silvia Rollefstad, Joseph Sexton, Eirik Ikdahl, Cynthia S. Crowson, Piet van Riel, George Kitas, Ian Graham, Anne M. Kerola, George Athanasios Karpouzas, Miguel A Gonzalez-Gay, Petros P Sfikakis, Maria G Tektonidou, Argyro Lazarini, Dimitrios Vassilopoulos, Bindee Kuriya, Carol Hitchon, Maria Simona Stoenoiu, Patrick Durez, Virginia Pascual-Ramos, Dionicio Angel Galarza-Delgado, Pompilio Faggiano, Durga Prasanna Misra, Andrew A Borg, Rong Mu, Erkin M Mirrakhimov, Diane Gheta, Karen Douglas, Vikas Agarwal, Svetlana Myasoedova, Lev Krougly, Tatiana Valentinovna Popkova, Alena Tuchyňová, Michal Tomcik, Michal Vrablik, Jiri Lastuvka, Pavel Horak & Helena Kaspar Medkova. (2022) Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit. IJC Heart & Vasculature 42, pages 101117.
Crossref
Crossref
Shanshan Sheehy, Gregg C. Fonarow, DaJuanicia N. Holmes, William R. Lewis, Roland A. Matsouaka, Jonathan P. Piccini, Lillian Zhi & Deepak L. Bhatt. (2022) Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States. Journal of the American Heart Association 11:4.
Crossref
Crossref
Eyob Alemayehu Gebreyohannes, Deanna Mill, Sandra Salter, Leanne Chalmers, Luke Bereznicki & Kenneth Lee. (2021) Strategies for improving guideline adherence of anticoagulants for patients with atrial fibrillation in primary healthcare: A systematic review. Thrombosis Research 205, pages 128-136.
Crossref
Crossref
Eyob Alemayehu Gebreyohannes, Sandra Salter, Leanne Chalmers, Luke Bereznicki & Kenneth Lee. (2020) Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence. American Journal of Cardiovascular Drugs 21:4, pages 419-433.
Crossref
Crossref
Carlos Escobar & A John Camm. (2021) Changing paradigms: from prevention of thromboembolic events to improved survival in patients with atrial fibrillation. EP Europace 23:6, pages 837-843.
Crossref
Crossref
Tatjana S Potpara, Gregory Y H Lip, Nikolaos Dagres, Harry J M G Crijns, Giuseppe Boriani, Paulus Kirchhof, Elena Arbelo, Irina Savelieva, Radoslaw Lenarczyk, Laurent Fauchier, Aldo P Maggioni & Chris P Gale. (2021) Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. European Heart Journal - Quality of Care and Clinical Outcomes 7:3, pages 229-237.
Crossref
Crossref
Nuredin Shiferaw Yimer, Alfoalem Araba Abiye, Shemsu Umer Hussen & Tamrat Assefa Tadesse. (2021) Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia. Clinical and Applied Thrombosis/Hemostasis 27, pages 107602962110497.
Crossref
Crossref
Xue Li, Swathi Pathadka, Kenneth K. C. Man, Vanessa W. S. Ng, Chung Wah Siu, Ian C. K. Wong, Esther W. Chan & Wallis C. Y. Lau. (2020) Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study. Drug Safety 43:10, pages 1023-1033.
Crossref
Crossref
Mei Wang, Anne Holbrook, Munil Lee, Jiayu Liu, Alvin Leenus, Nora Chen, Lawrence Mbuagbaw & Lehana Thabane. (2020) Barriers and facilitators to optimal oral anticoagulant management: a scoping review. Journal of Thrombosis and Thrombolysis 50:3, pages 697-714.
Crossref
Crossref
Matthew W. Sherwood, Jonathan P. PicciniDaJuanicia N. HolmesKaren S. PieperBenjamin A. SteinbergGregg C. FonarowLarry A. AllenGerald V. NaccarelliPeter R. KoweyBernard J. GershKenneth W. MahaffeyDaniel E. SingerJack E. AnsellJames V. FreemanPaul S. ChanJames A. ReiffelRosalia BlancoEric D. PetersonSunil V. Rao. (2020) Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice. Circulation: Cardiovascular Interventions 13:5.
Crossref
Crossref
Christine Gulla, Elisabeth Flo, Reidun L. S. Kjome & Bettina S. Husebo. (2019) Implementing a novel strategy for interprofessional medication review using collegial mentoring and systematic clinical evaluation in nursing homes (COSMOS). BMC Geriatrics 19:1.
Crossref
Crossref
Claudia Caroline Dobler, Allison S Morrow & Celia C Kamath. (2019) Clinicians’ cognitive biases: a potential barrier to implementation of evidence-based clinical practice. BMJ Evidence-Based Medicine 24:4, pages 137-140.
Crossref
Crossref
Eyob Alemayehu Gebreyohannes, Akshaya Srikanth Bhagavathula & Henok Getachew Tegegn. (2018) Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study. Thrombosis Journal 16:1.
Crossref
Crossref
J’Neka S. Claxton, Richard F. MacLehose, Pamela L. Lutsey, Faye L. Norby, Lin Y. Chen, Wesley T. O’Neal, Alanna M. Chamberlain, Lindsay G. S. Bengtson & Alvaro Alonso. (2018) A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants. PLOS ONE 13:9, pages e0203599.
Crossref
Crossref
Jonathan C. Hsu & James V. Freeman. (2018) Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review. Clinical Pharmacology & Therapeutics 104:2, pages 301-310.
Crossref
Crossref
Berith Hedberg, Dan Malm, Jan-Erik Karlsson, Kristofer Årestedt & Anders Broström. (2017) Factors associated with confidence in decision making and satisfaction with risk communication among patients with atrial fibrillation. European Journal of Cardiovascular Nursing 17:5, pages 446-455.
Crossref
Crossref
Reza Sheibani, Mehdi Sheibani, Alireza Heidari-Bakavoli, Ameen Abu-Hanna & Saeid Eslami. (2017) The Effect of a Clinical Decision Support System on Improving Adherence to Guideline in the Treatment of Atrial Fibrillation: An Interrupted Time Series Study. Journal of Medical Systems 42:2.
Crossref
Crossref
Lynndi M. Price & Elizabeth Hinton. (2017) Effect of International Normalized Ratio monitoring at home versus the clinic on monitoring adherence in adults taking oral anticoagulant medications: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 15:4, pages 905-913.
Crossref
Crossref
Ayrton Massaro, Robert P Giugliano, Bo Norrving, Ali Oto & Roland Veltkamp. (2016) Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants. International Journal of Stroke 11:9, pages 950-967.
Crossref
Crossref